Showing results (511-520 of 567) with videos related to
Sort By:
Pageof 57
JAMA Oncology|August 18, 2017
Efficacy and Safety of Durvalumab in Locally Advanced or Metastatic Urothelial Carcinoma: Updated Results From a Phase 1/2 Open-label StudyThomas Powles, Peter H O'Donnell, Christophe Massard, et al.Clinical Genitourinary Cancer|July 5, 2014
Impact of the number of prior lines of therapy and prior perioperative chemotherapy in patients receiving salvage therapy for advanced urothelial carcinoma: implications for trial designG R Pond, J Bellmunt, J E Rosenberg, et al.Diabetes, Obesity & Metabolism|May 30, 2025
Effects of dapagliflozin on sodium excretion, blood pressure and volume status in patients with type 2 diabetes and/or chronic kidney disease: The DAPASALT trialJelle M Beernink, Niels Jongs, Charlotte M Mosterd, et al.Journal of Geriatric Oncology|March 23, 2024
TOward a comPrehensive supportive Care intervention for Older men with metastatic Prostate cancer (TOPCOP3): A pilot randomized controlled trial and process evaluationShabbir M H Alibhai, Martine Puts, Rana Jin, et al.Nature Medicine|May 4, 2021
An adaptive, biomarker-directed platform study of durvalumab in combination with targeted therapies in advanced urothelial cancerThomas Powles, Danielle Carroll, Simon Chowdhury, et al.Clinical Genitourinary Cancer|March 8, 2020
Unfavorable Cancer-specific Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients With Bladder Cancer and Squamous Cell Variant: A Multi-institutional StudyMarco Bandini, Filippo Pederzoli, Russell Madison, et al.Clinical Genitourinary Cancer|January 1, 2018
Contemporary Patterns of Multidisciplinary Care in Patients With Muscle-invasive Bladder CancerLauren C Harshman, Abhishek Tripathi, Matthew Kaag, et al.The Journal of Urology|July 18, 2018
Impact of the Number of Cycles of Platinum Based First Line Chemotherapy for Advanced Urothelial CarcinomaGuru P Sonpavde, Luigi Mariani, Salvatore Lo Vullo, et al.Clinical Journal of the American Society of Nephrology : CJASN|December 12, 2025
Efficacy, Mechanisms and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Kidney Transplant Recipients: A Randomized, Double-Blind, Placebo-Controlled TrialVikas S Sridhar, Luxcia Kugathasan, Yuliya Lytvyn, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 15, 2017
Propensity Score Analysis of Radical Cystectomy Versus Bladder-Sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer ClinicGirish S Kulkarni, Thomas Hermanns, Yanliang Wei, et al.Pageof 57